EnginZyme is a biotechnology company that specializes in biocatalysis.
EnginZyme has raised €32M across 3 funding rounds from 6 investors, most recently a Series B round in Dec 2022. Based in Stockholm, Sweden; founded 2014; active in Software and Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-12-19 | Series B | €21M | Almi Invest Greentech,Bunge Ventures,Industrifonden,Navigare Ventures,SEB GreenTech VC,Sofinnova Partners | View deal → |
| 2021-02-11 | Other | €4.6M | Industrifonden | View deal → |
| 2020-04-22 | Series A | €6.4M | Sofinnova Partners | View deal → |
